EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Real-world retrospective analysis of clinical outcomes in pediatric acquired aplastic anemia: a single-center 10-year cohort study

Shanshan Li, Kai Chen, Hui Jiang, Na Zhang, Jingwei Yang, Xuelian Liao, Ting Zhang, Shayi Jiang, Jingbo Shao

Frontiers in Pediatrics · 13.08.2026 · 14

DOI: 10.3389/fped.2026.1915688 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Pediatrics, online erschienen am 13.08.2026. Verfasst von Shanshan Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pediatric aplastic anemia (AA), a rare and potentially fatal disease, demonstrates significant heterogeneity in pathogenesis, disease severity, therapeutic regimens, and clinical outcomes.

Methods

In this study, clinical features and outcomes of 70 children with AA, including severe AA (SAA, n = 30), very severe AA (vSAA, n = 21) and nonsevere AA (nSAA, n = 19), were retrospectively analyzed, with a median follow-up of 60.7 months (range, 0.4-136.5 months).

Results

Patients with nSAA were mainly treated with cyclosporine A, whereas SAA/vSAA patients primarily received allogeneic hematopoietic stem cell transplantation (HSCT) followed by standard immunosuppressive therapy (IST). Ultimate therapy regimens differed significantly between patients with SAA/vSAA and nSAA ( p = 0.001). SAA/vSAA group exhibited a higher overall response rate at the 2-year follow-up (85.5% vs. 55.6%, p = 0.019). The 2-year overall survival (OS) and event-free survival (EFS) for the entire cohort were 97.1% and 48.5%, respectively. In patients with SAA/vSAA, HSCT was associated with higher and faster cumulative complete response (CR) rate ( p < 0.0001) and superior EFS ( p = 0.0297) compared with IST. Two IST-resistant patients were observed to achieved CR with eltrombopag (EPAG) salvage therapy. Discussion pediatric AA carries excellent OS but suboptimal EFS. HSCT tends to yield more favorable EFS compared with IST in SAA/vSAA patients, and EPAG may act as an effective salvage option for appropriately selected IST-resistant individuals. Further multicenter prospective research is warranted prior to implementing these findings in routine clinical practice.

Schlagwörter

Stichwörter der Autor:innen

acquired aplastic anemiahematopoietic stem cell transplantationimmunosuppressive therapyoutcomepediatricthrombopoietin receptor agonist

Autor:innen und Institutionen

  • Department of Hematology and oncology, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Department of Gastroenterology, Hepatology and Nutrition, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
  • Gut Microbiota and Metabolic Research Center, Institute of Pediatric Infection, Immunity and Critical Care Medicine, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Zitieren

APA

Li, S., Chen, K., Jiang, H., Zhang, N., Yang, J., Liao, X., Zhang, T., Jiang, S., & Shao, J. (2026). Real-world retrospective analysis of clinical outcomes in pediatric acquired aplastic anemia: a single-center 10-year cohort study. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1915688

Vancouver

Li S, Chen K, Jiang H, Zhang N, Yang J, Liao X, et al. Real-world retrospective analysis of clinical outcomes in pediatric acquired aplastic anemia: a single-center 10-year cohort study. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1915688

BibTeX
@article{Li2026,
  author = {Li, Shanshan and Chen, Kai and Jiang, Hui and Zhang, Na and Yang, Jingwei and Liao, Xuelian and Zhang, Ting and Jiang, Shayi and Shao, Jingbo},
  title = {Real-world retrospective analysis of clinical outcomes in pediatric acquired aplastic anemia: a single-center 10-year cohort study},
  journal = {Frontiers in Pediatrics},
  year = {2026},
  volume = {14},
  doi = {10.3389/fped.2026.1915688}
}
Kostenlos starten →